Ulrika WARPMAN BERGLUND

Ulrika WARPMAN BERGLUND

Company: Oxcia

Job title: Chief Executive Officer

Seminars:

Harnessing Oxidative Stress & DNA Damage Response Pathways for Innovative Antifibrotic Therapies 2:00 pm

Exploring the role of the enzyme OGG1 in excision repair and cellular reprogramming in inflammatory and fibrotic diseases, and detailing the promise of OGG1 inhibitors to halt inflammation and fibrosis Examining the potential of OXC-201 to offer curative solutions rather than merely symptomatic reliefRead more

day: Day Two

OUR CONTACT DETAILS

Phone
UK: +44 (0)20 3141 8700
US: +1 617 455 4188

Email
info@hansonwade.com

JOIN OUR TEAM

We are always looking for ambitious people to join our team. You'll have opportunities to learn quickly, advance your career, and to meaningfully impact our customers and our business.

Click here to learn about careers.

ABOUT US

Hanson Wade specializes in scientific research across a comprehensive range of distinctive R&D areas. We deliver insight and connections to facilitate safe and effective drug development for more personalized and targeted patient populations.

EXPLORE OUR PRODUCTS

Conferences Beacon
Searchlight Intelligence

SEARCH

ORGANIZED BY

Terms & Conditions

Privacy Policy

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.